DKSH Technology - Malaysia & Singapore to Distribute VisualSonics’ Vevo 770® High-Resolution In Vivo Imaging System for the Preclinical Life Sciences Research Market in Singapore and Malaysia

August 30, 2005: TORONTO, CANADA KUALA LUMPUR, MALAYSIA and SINGAPORE: VisualSonics Inc. is pleased to announce that DKSH Technology - Malaysia & Singapore will distribute its Vevo 770® high-resolution in vivo imaging system for use with small animals in the life sciences research market. “We are delighted to be working with DKSH Technology - Malaysia & Singapore to offer our high-resolution micro-imaging system to the academic and preclinical pharmaceutical researchers in Singapore and Malaysia”, said Tom Little, CEO of VisualSonics Inc. “The adoption of the Vevo technology in Asia has been significant and we are sure that the expertise and wide-spread distribution offered by the DKSH Technology - Malaysia & Singapore team will extend our penetration into this developing market”. DKSH Technology - Malaysia & Singapore, among its many lines of business, is a leading distributor of life science products for the preclinical pharmaceutical and academic research markets in Singapore and Malaysia. “There is significant demand in the Singapore and Malaysian markets for increasing non-invasive phenotyping and optimizing preclinical drug development efforts - - including benefits derived from in vivo imaging”, says Chandrika Naginlal, Department Manager of Life Sciences for DKSH Technology - Malaysia. ”The Vevo 770 provides such benefits and will be highly attractive to our commercial and research customers, especially since they can benefit from the local support and technical expertise of DKSH Technology - Malaysia & Singapore .”

About VisualSonics

VisualSonics Inc. (www.visualsonics.com) is the leading manufacturer of high-resolution in vivo imaging systems for small animal research. VisualSonics’ Vevo 770® high-resolution imaging system provides real-time visualization and measurements in small animals down to 30 microns. Because of the non-invasive nature of the technology, longitudinal studies of the same animal can be performed. This high-resolution imaging technology is being successfully applied to phenotypic-based research applications such as developmental biology, cardiovascular research, cancer biology, neurobiology and preclinical drug discovery.

About DKSH Technology – Malaysia & Singapore

DKSH Technology – Malaysia and Singapore is part of the DKSH group, the No.1 services group in Asia focusing on sourcing, marketing and distribution. Founded and deeply rooted in Asia, DKSH successfully bridges complex markets within and between Asia, Europe and Americas. DKSH Technology – Malaysia and Singapore is the leading provider of solution based technology products and services in the area of Life Sciences which includes proteomics, genomics, drug discovery, pharmaceuticals and medical. Apart from sales and distribution they have an excellent after sales service network consisting of highly trained personnel in both Malaysia and Singapore, ensuring users of prompt and reliable support.

For more information, contact:

VisualSonics Contact: 
Tom Little 
President and CEO 
VisualSonics Inc. 
Toronto, Canada 
Tel. 416.484.5010 
Email tlittle@visualsonics.com

DKSH Technology Contact: 
Nick Grantham 
Managing Director 
DKSH Technology – Malaysia 
Chandrika Naginlal 
Department Manager Life Sciences

Siber Hegner (M) Sdn Bhd 
No. 14 Jalan Bersatu 13/4 
46200 Petaling Jaya 
Selangor Darul Ehsan, MALAYSIA 
Tel : +603 7954 8888 Mobile: +60-12-2010156 (mobile) 
Fax : +603 7954 8877 
e-mail : Chandrika.Naginlal@SiberHegner.com.my 
Web: www.dksh.com

SINGAPORE

Nick Grantham 
Managing Director Divisional Manager 
Kelvin Low

DKSH Technology - Singapore